MedPath

ROPIVACAINE HYDROCHLORIDE INJECTION, USP

ROPIVACAINE HYDROCHLORIDE INJECTION, USP

Approved
DIN Number

02439387

Drug Class

Human

Market Date

Sep 13, 2019

Company
HC

fresenius kabi canada ltd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02439387
AIG Number0133273003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
N01BB09 ROPIVACAINE
Product Specifications
Dosage FormSolution
Route of AdministrationEpidural ,  Block/Infiltration
AHFS Classification72:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ROPIVACAINE HYDROCHLORIDEActive
Strength: 5 MG / ML
Monograph: ROPIVACAINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.